Marcos Maria Angeles, Esperatti Mariano, Torres Antoni
Department of Microbiology, Hospital Clínic i Provincial de Barcelona, Spain.
Curr Opin Infect Dis. 2009 Apr;22(2):143-7. doi: 10.1097/QCO.0b013e328328cf65.
Community-acquired pneumonia (CAP) has traditionally focused little on viral causes, and few studies have done an extensive and appropriate evaluation for viral cause. The purpose of the present article is to review several issues of viral infection in CAP in light of recent studies that included exhaustive evaluation of viruses.
The introduction of better quality diagnostic tests, such as nucleic acid amplification techniques, have markedly improved our ability to detect multiple viral pathogens. With these diagnostic tools, a viral cause can be established in more than half of patients with CAP. Influenza A and respiratory syncytial virus are the most frequent causes of viral pneumonia followed by adenovirus, parainfluenza virus types 1, 2, and 3, and influenza. Although some clinical findings have been more frequent with viral infection, no clear-cut clinical signs have been shown to be predictive of specific cause. Of more interest is the association of mixed virus-bacteria infection with poorer severity scores found in some studies. The diagnostic approach with new techniques should be taken for a true estimation of viral infection in epidemiologic studies.Unfortunately, there are no other licensed antivirals or vaccines against the large variety of clinically important respiratory viruses with the notable exception of influenza.
Given the high rate of viral infection in CAP and its probable association with poorer prognosis in mixed virus-bacteria infection, an extensive evaluation for virus in some populations seems appropriate. These findings can be useful for a more appropriate management of these patients.
社区获得性肺炎(CAP)传统上很少关注病毒病因,很少有研究对病毒病因进行广泛且恰当的评估。本文旨在根据近期对病毒进行详尽评估的研究,综述CAP中病毒感染的若干问题。
核酸扩增技术等质量更好的诊断检测方法的引入,显著提高了我们检测多种病毒病原体的能力。借助这些诊断工具,超过半数的CAP患者可确定病毒病因。甲型流感病毒和呼吸道合胞病毒是病毒性肺炎最常见的病因,其次是腺病毒、1、2和3型副流感病毒以及流感病毒。虽然某些临床症状在病毒感染时更常见,但尚无明确的临床体征可预测具体病因。更值得关注的是,一些研究发现病毒-细菌混合感染与更严重的病情评分相关。在流行病学研究中,应采用新技术的诊断方法来准确评估病毒感染。不幸的是,除流感外,针对多种临床上重要的呼吸道病毒,尚无其他获批的抗病毒药物或疫苗。
鉴于CAP中病毒感染率高及其在病毒-细菌混合感染中可能与较差预后相关,对某些人群进行广泛的病毒评估似乎是合适的。这些发现有助于更恰当地管理这些患者。